Roger L Papke1, Clare Stokes1, M Imad Damaj2, Ganesh A Thakur3, Khan Manther1, Millet Treinin4, Deniz Bagdas2,5, Abhijit R Kulkarni3, Nicole A Horenstein6. 1. Department of Pharmacology and Therapeutics, University of Florida, Gainesville, FL, USA. 2. Department of Pharmacology and Toxicology, Medical College of Virginia Campus, Virginia Commonwealth University, Richmond, VA, USA. 3. Department of Pharmaceutical Sciences, Northeastern University, Boston, MA, USA. 4. Department of Medical Neurobiology, Hadassah Medical School, Hebrew University, Jerusalem, Israel. 5. Experimental Animals Breeding and Research Center, Faculty of Medicine, Uludag University, Bursa, Turkey. 6. Department of Chemistry, University of Florida, Gainesville, FL, USA.
Abstract
BACKGROUND AND PURPOSE: GAT107 ((3aR,4S,9bS)-4-(4-bromo-phenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta-[c]quinoline-8-sulfonamide) is a positive allosteric modulator (PAM) and agonist of α7 nicotinic acetylcholine receptors (nAChRs)that can cause a prolonged period of primed potentiation of acetylcholine responses after drug washout. NS6740 is a silent agonist of α7 nAChRs that has little or no efficacy for activating the ion channel but induces stable desensitization states, some of which can be converted into channel-active states by PAMs. Although GAT107 and NS6740 appear to stably induce different non-conducting states, both agents are effective treatment for inflammation and inflammatory pain models. We sought to better understand how both of these drugs that have opposite effects on channel activation could regulate signal transduction. EXPERIMENTAL APPROACH: Voltage-clamp experiments were conducted with α7 nAChRs expressed in Xenopus oocytes. KEY RESULTS: Long-lived sensitivity to a PAM or to an agonist was produced by NS6740 or GAT107 respectively. With sequential applications, these two drugs induced varying levels of persistent activation, which is a unique condition for a receptor that is known for rapid desensitization. The non-conducting states induced by NS6740 or GAT107 differ in their sensitivity to an α7 nAChR-selective antagonist and in how effectively they promote current. CONCLUSIONS & IMPLICATIONS: Our data suggest that the persistent currents represent a dynamic interconversion between different stable desensitized states and the PAM-inducible conducting states. However, the similarity of NS6740 and GAT107 effects on inflammation and pain suggests that the different stable non-conducting states have common activity on signal transduction. LINKED ARTICLES: This article is part of a themed section on Nicotinic Acetylcholine Receptors. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.11/issuetoc.
BACKGROUND AND PURPOSE: GAT107 ((3aR,4S,9bS)-4-(4-bromo-phenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta-[c]quinoline-8-sulfonamide) is a positive allosteric modulator (PAM) and agonist of α7 nicotinic acetylcholine receptors (nAChRs)that can cause a prolonged period of primed potentiation of acetylcholine responses after drug washout. NS6740 is a silent agonist of α7 nAChRs that has little or no efficacy for activating the ion channel but induces stable desensitization states, some of which can be converted into channel-active states by PAMs. Although GAT107 and NS6740 appear to stably induce different non-conducting states, both agents are effective treatment for inflammation and inflammatory pain models. We sought to better understand how both of these drugs that have opposite effects on channel activation could regulate signal transduction. EXPERIMENTAL APPROACH: Voltage-clamp experiments were conducted with α7 nAChRs expressed in Xenopus oocytes. KEY RESULTS: Long-lived sensitivity to a PAM or to an agonist was produced by NS6740 or GAT107 respectively. With sequential applications, these two drugs induced varying levels of persistent activation, which is a unique condition for a receptor that is known for rapid desensitization. The non-conducting states induced by NS6740 or GAT107 differ in their sensitivity to an α7 nAChR-selective antagonist and in how effectively they promote current. CONCLUSIONS & IMPLICATIONS: Our data suggest that the persistent currents represent a dynamic interconversion between different stable desensitized states and the PAM-inducible conducting states. However, the similarity of NS6740 and GAT107 effects on inflammation and pain suggests that the different stable non-conducting states have common activity on signal transduction. LINKED ARTICLES: This article is part of a themed section on Nicotinic Acetylcholine Receptors. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.11/issuetoc.
Authors: Gareth T Young; Ruud Zwart; Alison S Walker; Emanuele Sher; Neil S Millar Journal: Proc Natl Acad Sci U S A Date: 2008-09-12 Impact factor: 11.205
Authors: Huashan Peng; Robert L Ferris; Tonya Matthews; Hakim Hiel; Andres Lopez-Albaitero; Lawrence R Lustig Journal: Life Sci Date: 2004-12-03 Impact factor: 5.037
Authors: Y Villiger; I Szanto; S Jaconi; C Blanchet; B Buisson; K-H Krause; D Bertrand; J-A Romand Journal: J Neuroimmunol Date: 2002-05 Impact factor: 3.478
Authors: Roger L Papke; Nicole A Horenstein; Abhijit R Kulkarni; Clare Stokes; Lu W Corrie; Cheol-Young Maeng; Ganesh A Thakur Journal: J Biol Chem Date: 2013-12-20 Impact factor: 5.157
Authors: Stephen Ph Alexander; John A Peters; Eamonn Kelly; Neil Marrion; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Christopher Southan; Jamie A Davies Journal: Br J Pharmacol Date: 2015-12 Impact factor: 8.739
Authors: Marta Quadri; Almin Silnović; Carlo Matera; Nicole A Horenstein; Clare Stokes; Marco De Amici; Roger L Papke; Clelia Dallanoce Journal: Eur J Med Chem Date: 2018-10-11 Impact factor: 6.514
Authors: Maria Chiara Pismataro; Nicole A Horenstein; Clare Stokes; Marta Quadri; Marco De Amici; Roger L Papke; Clelia Dallanoce Journal: Eur J Med Chem Date: 2020-07-28 Impact factor: 6.514